FERMT1 is upregulated in breast cancer, colon cancer, hepatocellular carcinoma, lung cancer, and pancreatic cancer.31 FERMT1 also appears to be a tumor driver in cutaneous epithelial cells. Here, FERMT1 is linked to familial pancreatic carcinoma.